The Harvard University Board of Overseers appoints a visiting committee to report on each professional school at the University. The committee—consisting of key alumni active in relevant fields, distinct experts outside the Harvard network, and select Overseer members—convenes every two years to meet with HMS senior leadership, faculty, student, and affiliate representatives and assess the quality and effectiveness of the Medical School’s objectives for excellence in education, teaching, and research.

Vineeta Agarwala
Adjunct Clinical Assistant Professor, Stanford School of Medicine; General Partner, Andreessen Horowitz (a16z)

Monica Bharel
Associate Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine

Jue Chen
Professor, Head of Laboratory, Laboratory of Membrane Biology and Biophysics, The Rockefeller University

Henri R. Ford
Dean and Chief Academic Officer, University of Miami Miller School of Medicine

Levi Garraway
Executive Vice President, Head of Product Development and Chief Medical Officer, Genentech/Roche

Cato T. Laurencin
University Professor and Chief Executive Officer, The Cato T. Laurencin Institute for Regenerative Engineering, The University of Connecticut

Yvonne Maldonado
Senior Associate Dean for Faculty Development and Diversity; Taube Endowed Professor of Global Health and Infectious Diseases; Professor of Pediatrics and of Epidemiology and Population Health; Interim Chair, Department of Medicine, Stanford University School of Medicine

Elizabeth Ofili
Professor of Medicine (Cardiology), Morehouse School of Medicine

David C. Page (Chair)
Member, Whitehead Institute; Professor of Biology, Massachusetts Institute of Technology; Investigator, Howard Hughes Medical Institute

Thomas D. Pollard
Visiting Professor of Molecular and Cell Biology, University of California Berkeley

Peter J. Polverini
Jonathan Taft Distinguished University Professor of Dentistry, University of Michigan School of Dentistry

Robert L. Satcher, Jr. (Overseer)
Associate Professor, Department of Orthopedic Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center